2021 National Biotechnology Conference (NBC) | AAPS Conferences

2021 National Biotechnology Conference (NBC)

56 Presentations 5 Sections

The National Biotechnology Conference (NBC) explores the latest research and ideas in its field. It features three tracks focused on nucleic-acid-based therapies; antibody therapies; and cell-based therapies.

Presentation Icon

Opening Plenary: CAR-T Cell Therapies: From Origin to Acceleration

Presentation: Bruce Levine, Ph.D., 75 min 42 sec

Presentation Icon

Closing Plenary: Accelerating Biomedical Innovation via Novel Financing Structures

Presentation: Andrew Lo, Ph.D., 74 min 48 sec

Event Section Icon

Antibody Therapies: Tackling New Frontiers

Section: 12 Presentations

Event Section Icon

Cell-Based Therapies: The Future of Regenerative Medicine

Section: 14 Presentations

Event Section Icon

Next in Sequence? Nucleic-Acid-Based Therapies: Current State and Future Promise

Section: 14 Presentations

Event Section Icon

Career Development

Section: 8 Presentations

Event Section Icon

Partner Presentations

Section: 4 Presentations

Roundtable Talk: Enhancing Subcutaneous Administration of Monoclonal Antibodies Using Hyaluronidase (rHuPH20)

Presentation: Nothing uploaded yet

Partner Presentation: Phenotypic Screening Hit Target Deconvolution Using Pooled CRISPR/Cas9 Screening Technology

Presentation: Nothing uploaded yet